Items where Author is "Vilar, Enric"
Number of items: 31.
Article
Impact of Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy on Endogenous Fibrinolysis in Acute Coronary Syndrome: The VaLiDate-R study. (2024)
Ying X. Gue,
Vassilios Memtsas,
Rahim Kanji,
David Wellsted,
Amanda Busby,
Megan Smith,
Enric Vilar,
Alisdair Ryding,
Deepa J. Arachchillage
and
Diana Gorog
Impact of incremental initiation of haemodialysis on mortality: a systematic review and meta-analysis. (2023)
Emma Caton,
Shivani Sharma,
Enric Vilar
and
Kenneth Farrington
Patient Preferences for Longer or More Frequent In-Center Hemodialysis Regimens: A Multicenter Discrete Choice Study. (2022)
James Fotheringham,
Enric Vilar,
Tarun Bansal,
Paul Laboi,
Andrew Davenport,
Louese Dunn
and
Arne Risa Hole
Prevalence and outcomes of chronic liver disease in patients receiving dialysis: systematic review and meta-analysis. (2021)
Oscar Swift,
Shivani Sharma,
Sivaramakrishnan Ramanarayanan,
Hamza Umar,
Keith Laws,
Enric Vilar
and
Kenneth Farrington
A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function. (2021)
Enric Vilar,
Raja M Kaja Kamal,
James Fotheringham,
Amanda Busby,
Jocelyn Berdeprado,
Ewa Kislowska,
David Wellsted,
Bassam Alchi,
James O Burton,
Andrew Davenport
and
Ken Farrington
Energy expenditure estimates in chronic kidney disease using a novel physical activity questionnaire. (2021)
Sivakumar Sridharan,
Enric Vilar,
Sivaramakrishnan Ramanarayanan,
Andrew Davenport
and
Ken Farrington
Impact of incremental versus conventional initiation of haemodialysis on residual kidney function : study protocol for a multicentre feasibility randomised controlled trial. (2020)
Raja Mohammed Kaja Kamal,
Ken Farrington,
David Wellsted,
Sivakumar Sridharan,
Bassam Alchi,
James Burton,
Andrew Davenport
and
Enric Vilar
Beta-glucans in advanced CKD : role in endotoxaemia and inflammation. (2020)
Jonathan Wong,
Yonglong Zhang,
Oscar Swift,
Malcolm Finkelman,
Ashish Patidar,
Sivaramakrishnan Ramanarayanan,
Enric Vilar
and
Ken Farrington
Initiating haemodialysis twice-weekly as part of an incremental programme may protect residual kidney function. (2018)
Raja Mohammed Kaja Kamal,
Ken Farrington,
Amanda D Busby,
David Wellsted,
Humza Chandna,
Laura J Mawer,
Sivakumar Sridharan
and
Enric Vilar
Scaling Hemodialysis Target Dose to Reflect Body Surface Area, Metabolic Activity, and Protein Catabolic Rate : A Prospective, Cross-sectional Study. (2017)
Sivakumar Sridharan,
Enric Vilar,
Andrew Davenport,
Neil Ashman,
Michael Almond,
Anindya Banerjee,
Justin Roberts
and
Kenneth Farrington
Attitudes in Patients with Autosomal Dominant Polycystic Kidney Disease Toward Prenatal Diagnosis and Preimplantation Genetic Diagnosis. (2016)
Oscar Swift,
Enric Vilar,
Belinda Rahman,
Lucy Side
and
Daniel P Gale
Is Endotoxemia in Stable Hemodialysis Patients an Artefact? : Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan. (2016)
Jonathan Wong,
Yonglong Zhang,
Ashish Patidar,
Enric Vilar,
Malcolm Finkelman
and
Kenneth Farrington
A comparative study of blood endotoxin detection in haemodialysis patients. (2016)
Jonathan Wong,
Nathan Davies,
Hasan Jeraj,
Enric Vilar,
Adie Viljoen
and
Kenneth Farrington
The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients. (2015)
Murugan Sivalingam,
Enric Vilar,
Suresh Mathavakkannan
and
Kenneth Farrington
Plasma Levels of Middle Molecules to Estimate Residual Kidney Function in Haemodialysis without Urine Collection. (2015)
Enric Vilar,
Capella Boltiador,
Jonathan Wong,
Adie Viljoen,
Ashwini Machado,
Arani Uthayakumar
and
Kenneth Farrington
Endotoxemia in end-stage kidney disease. (2015)
Jonathan Wong,
Enric Vilar
and
Kenneth Farrington
Endotoxin detection in end-stage kidney disease. (2015)
Jonathan Wong,
Hassan Jeraj,
Enric Vilar,
Adie Viljoen
and
Kenneth Farrington
A self-report comorbidity questionnaire for haemodialysis patients. (2014)
Sivakumar Sridharan,
Jocelyn Berdeprado,
Enric Vilar,
Justin Roberts
and
Ken Farrington
Removal and rebound kinetics of cystatin C in high-flux hemodialysis and hemodiafiltration. (2014)
Enric Vilar,
Capella Boltiador,
Adie Viljoen,
Ashwini Machado
and
Kenneth Farrington
Disease-specific predictive formulas for energy expenditure in the dialysis population. (2014)
Enric Vilar,
Ashwini Machado,
Andrew Garrett,
Robert Kozarski,
D. Wellsted
and
Ken Farrington
Energy metabolism, body composition, and urea generation rate in hemodialysis patients. (2013)
Sivakumar Sridharan,
Enric Vilar,
Jocelyn Berdeprado
and
Ken Farrington
Optimizing home dialysis : role of hemodiafiltration. (2011)
Enric Vilar,
Ken Farrington,
C. Bates,
C. Mumford
and
R.N. Greenwood
Creatinine reduction ratio : a useful marker to identify medium and high-risk renal transplants. (2010)
Enric Vilar,
Mira Varagunam,
Muhammad M Yaqoob,
Martin Raftery
and
Raj Thuraisingham
Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. (2009)
Enric Vilar,
D. Wellsted,
S.M. Chandna,
R.N. Greenwood
and
Ken Farrington
An Association between Residual Renal Function and Depression Symptoms in Haemodialysis Patients. (2009)
J. Chilcot,
D. Wellsted,
Enric Vilar
and
Ken Farrington
Long-Term Outcomes in Online Hemodiafiltration and High-Flux Hemodialysis : A Comparative Analysis. (2009)
Enric Vilar,
A.C. Fry,
D. Wellsted,
J.E. Tattersall,
R.N. Greenwood
and
Ken Farrington